SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Biotech / Medical
Cytori Therapeutics, Inc.
An SI Board Since August 2005
Posts SubjectMarks Bans Symbol
251 17 0 CYTX
Emcee:  SnowShredder Type:  Moderated
From their website...

cytoritx.com

"Cytori Therapeutics is discovering and developing proprietary, cell-based therapeutics utilizing adult stem cells derived from adipose, also known as fat tissue. The Company's investigational therapies target cardiovascular disease, spine and orthopedic conditions, gastrointestinal disorders and new approaches for aesthetic and reconstructive surgery. To facilitate processing and delivery of adipose stem cells, Cytori is developing its proprietary Celution™ system to isolate and concentrate a patient's own stem cells in approximately a one-hour period of time. This system will dramatically improve the speed in which personalized, cell-based therapies can be delivered to patients.

Cytori's MacroPore Biosurgery division develops and manufactures innovative bioresorbable, surgical implants. MacroPore Biosurgery manufactures the HYDROSORB™ family of FDA-cleared bioresorbable spine and orthopedic implants, which are distributed worldwide exclusively through Medtronic, Inc. Additionally, MacroPore Biosurgery is developing Thin Film bioresorbable implants exclusively for Senko Medical Trading Co., which has distribution rights exclusively in Japan."
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
251Multiple miRNA Markers Associated with Angiogenesis and Tissue Injury Repair ExpSnowShredder-10/7/2012
250Cytori Awarded Contract Valued up to $106 Million by Biomedical Advanced ResearcSnowShredder-9/28/2012
249Restore 2 publication... Prospective trial of Adipose-Derived Regenerative CellSnowShredder-3/27/2012
248Stem cells from fat win favor with heart researcher For future reference... rSnowShredder-3/25/2012
247FDA Grants Cytori 510(k) Clearance for Puregraft(R) 850 SAN DIEGO, CA--(MarketwSnowShredder-3/16/2012
246Adipose Stem Cell Heart Attack Trial Data Published in Journal of the American CSnowShredder-1/24/2012
245Terrell Owens uses fat stem cells to speed up recovery of his knee (~1:30 into tSnowShredder-10/6/2011
244CYTORI ENTERS STRATEGIC EQUITY DEAL WITH ASTELLAS PHARMA; TO SELL $10 MILLION INSnowShredder-12/7/2010
243Chronic Radiation Injury treatment publication, free to download the pdf... sagSnowShredder-12/3/2010
242Adipose-Derived Regenerative Cells Improve Cardiac Functional Capacity at 18 Montnsaf-11/17/2010
241Cytori Announces Exercise in Full of Overallotment Option and Closing of Public tnsaf-10/13/2010
240Cytori Therapeutics Prices Public Offering of Common Stock SAN DIEGO, Oct 08, 2tnsaf-10/9/2010
239Adipose-Derived Stem & Regenerative Cells Reduce Mortality, Improve Renal Futnsaf-10/7/2010
238Cytori's stem-cell device gets European approval for new uses Best of Luck,SnowShredder-8/6/2010
237Just one letter off in its ticker, but this was ALMOST good news for Cytori... Ian@SI-7/22/2010
236<PRECISE> Cytori Reports Stem & Regenerative Cells from Body Fat ProduSnowShredder-5/7/2010
235<APOLLO> Cytori Reports Stem & Regenerative Cells from Body Fat ImprovSnowShredder-5/7/2010
234Stock option benefit narrows Cytori 1Q loss Cytori posts smaller 1st-qtr loss dutnsaf-5/6/2010
233Cytori Stem Cell Cardiac Data Preview By Adam Feuerstein 05/05/10 - 11:48 AM EDTtnsaf-5/6/2010
232"FDA is requiring them to do a trial for cosmetic application." I taktuck-3/13/2010
231Hi Tuck, FDA is requiring them to do a trial for cosmetic application. It is aSnowShredder-3/13/2010
230Cytori firesaling on greater than expected expenses. I don't follow the comtuck-3/12/2010
229Duckers et al (ACC poster title)... "First-in-Man Experience of Adipose-DeSnowShredder-3/12/2010
228FDA decision due soon, Apollo trial abstract at ACC in March...should be interesSnowShredder-2/18/2010
227Periurethral injection of autologous adipose-derived stem cells for the treatmenSnowShredder-2/18/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):